The role of Vpr in the regulation of HIV-1 gene expression

被引:21
作者
Cui, Jianqi
Tungaturthi, Parithosh K.
Ayyavoo, Velpandi
Ghafouri, Mohammad
Ariga, Hiroyoshi
Khalili, Kamel
Srinivasan, Alagarsamy
Amini, Shohreh
Sawaya, Bassel E.
机构
[1] Temple Univ, Sch Med, Ctr Neurovirol, Dept Neurosci, Philadelphia, PA 19122 USA
[2] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA
[3] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA USA
[4] Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido, Japan
[5] Temple Univ, Coll Sci & Technol, Dept Biol, Philadelphia, PA 19122 USA
基金
美国国家卫生研究院;
关键词
HIV-1VPr; p21; WAF1; transcription; cell cycle; HIV-1; infection;
D O I
10.4161/cc.5.22.3442
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Expression of the viral protein R, Vpr, of HIV-1 affects many biological events in host cells including cell cycle progression, and modulates HIV-1 gene transcription. Earlier studies implicating the cellular protein p21(WAF1) (p21) in regulation of HIV-1 transcription, led us to investigate the functional and physical interaction of Vpr and p21. Our results show that Vpr modestly activated HIV-LTR in cells lacking p21 gene. Here, we describe the mechanisms by which p21 and Vpr leading to stimulation of HIV-1 transcription. Data from the protein-protein interaction experiments revealed the ability of Vpr, p21 and p300 to form a complex. Further, we show that, Vpr interacts with the N- and the C-terminal domains of p21. Furthermore, in cells expressing Vpr, p21 localizes to both the cytoplasm and the nucleus. Interestingly, expression of Vpr alleviates p21-mediated inhibition of cell departure from G1 phase. Expression of a mutant Vpr, with arginine 73 altered to serine, did not affect the ability of p21 to cause cells arrest or its sub-cellular localization. These observations reveal a new cellular partner for Vpr, and provide a new therapeutic avenue for controlling HIV-1 expression.
引用
收藏
页码:2626 / 2638
页数:13
相关论文
共 74 条
  • [11] CHEN IT, 1995, ONCOGENE, V11, P1931
  • [12] SEPARATE DOMAINS OF P21 INVOLVED IN THE INHIBITION OF CDK KINASE AND PCNA
    CHEN, JJ
    JACKSON, PK
    KIRSCHNER, MW
    DUTTA, A
    [J]. NATURE, 1995, 374 (6520) : 386 - 388
  • [13] HIV-1 Vpr activates cell cycle inhibitor p21/Waf1/Cip1: A potential mechanism of G2/M cell cycle arrest
    Chowdhury, IH
    Wang, XF
    Landau, NR
    Robb, ML
    Polonis, VR
    Birx, DL
    Kim, JH
    [J]. VIROLOGY, 2003, 305 (02) : 371 - 377
  • [14] Human DNA (cytosine-5) methyltransferase PCNA complex as a target for p21(WAF1)
    Chuang, LSH
    Ian, HI
    Koh, TW
    Ng, HH
    Xu, GL
    Li, BFL
    [J]. SCIENCE, 1997, 277 (5334) : 1996 - 2000
  • [15] Loss of G1/S checkpoint in human immunodeficiency virus type 1-infected cells is associated with a lack of cyclin-dependent kinase inhibitor p21/Waf1
    Clark, E
    Santiago, F
    Deng, LW
    Chong, SY
    de la Fuente, C
    Wang, L
    Fu, P
    Stein, D
    Denny, T
    Lanka, V
    Mozafari, F
    Okamoto, T
    Kashanchi, F
    [J]. JOURNAL OF VIROLOGY, 2000, 74 (11) : 5040 - 5052
  • [16] COHEN EA, 1990, J ACQ IMMUN DEF SYND, V3, P11
  • [17] New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment?
    Coqueret, O
    [J]. TRENDS IN CELL BIOLOGY, 2003, 13 (02) : 65 - 70
  • [18] Dynamic disruptions in nuclear envelope architecture and integrity induced by HIV-1 Vpr
    de Noronha, CMC
    Sherman, MP
    Lin, HW
    Cavrois, MV
    Moir, RD
    Goldman, RD
    Greene, WC
    [J]. SCIENCE, 2001, 294 (5544) : 1105 - 1108
  • [19] WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION
    ELDEIRY, WS
    TOKINO, T
    VELCULESCU, VE
    LEVY, DB
    PARSONS, R
    TRENT, JM
    LIN, D
    MERCER, WE
    KINZLER, KW
    VOGELSTEIN, B
    [J]. CELL, 1993, 75 (04) : 817 - 825
  • [20] HIV transcriptional activation by the accessory protein, VPR, is mediated by the p300 co-activator
    Felzien, LK
    Woffendin, C
    Hottiger, MO
    Subbramanian, RA
    Cohen, EA
    Nabel, GJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (09) : 5281 - 5286